ANGSTRO-TECHNOLOGY Trademark

Trademark Overview

On Wednesday, November 13, 2019, a trademark application was filed for ANGSTRO-TECHNOLOGY with the United States Patent and Trademark Office. The USPTO has given the ANGSTRO-TECHNOLOGY trademark a serial number of 88690384. The federal status of this trademark filing is ABANDONED - NO STATEMENT OF USE FILED as of Monday, June 26, 2023. This trademark is owned by TONIX PHARMACEUTICALS, INC.. The ANGSTRO-TECHNOLOGY trademark is filed in the Pharmaceutical Products category with the following description:

Pharmaceutical preparations for the treatment of sleep disorders, fibromyalgia, post-traumatic stress disorder, functional somatic disorder, addiction, alcoholism, disorders of the nervous system, disorders of the musculo-skeletal system, disorders of the endocrine system, disorders of the musculoskeletal system, neurological disorders, hormonal disorder, psychiatric related diseases and disorders
angstro-technology

General Information

Serial Number88690384
Word MarkANGSTRO-TECHNOLOGY
Filing DateWednesday, November 13, 2019
Status606 - ABANDONED - NO STATEMENT OF USE FILED
Status DateMonday, June 26, 2023
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, March 31, 2020

Trademark Statements

Goods and ServicesPharmaceutical preparations for the treatment of sleep disorders, fibromyalgia, post-traumatic stress disorder, functional somatic disorder, addiction, alcoholism, disorders of the nervous system, disorders of the musculo-skeletal system, disorders of the endocrine system, disorders of the musculoskeletal system, neurological disorders, hormonal disorder, psychiatric related diseases and disorders

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateTuesday, November 19, 2019
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History

Party NameTONIX PHARMACEUTICALS, INC.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressNew York, NY 10022
Party NameTONIX PHARMACEUTICALS, INC.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressNew York, NY 10022

Trademark Events

Event DateEvent Description
Monday, June 26, 2023ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED
Monday, June 26, 2023ABANDONMENT - NO USE STATEMENT FILED
Wednesday, November 23, 2022NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Tuesday, November 22, 2022SOU EXTENSION 5 GRANTED
Friday, November 11, 2022SOU EXTENSION 5 FILED
Tuesday, November 22, 2022CASE ASSIGNED TO INTENT TO USE PARALEGAL
Friday, November 11, 2022TEAS EXTENSION RECEIVED
Tuesday, May 24, 2022NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Friday, May 20, 2022SOU EXTENSION 4 GRANTED
Friday, May 20, 2022SOU EXTENSION 4 FILED
Friday, May 20, 2022TEAS EXTENSION RECEIVED
Thursday, November 25, 2021NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Tuesday, November 23, 2021SOU EXTENSION 3 GRANTED
Tuesday, November 23, 2021SOU EXTENSION 3 FILED
Tuesday, November 23, 2021TEAS EXTENSION RECEIVED
Saturday, May 15, 2021NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Thursday, May 13, 2021SOU EXTENSION 2 GRANTED
Thursday, May 13, 2021SOU EXTENSION 2 FILED
Thursday, May 13, 2021TEAS EXTENSION RECEIVED
Friday, June 5, 2020NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Wednesday, June 3, 2020SOU EXTENSION 1 GRANTED
Wednesday, June 3, 2020SOU EXTENSION 1 FILED
Wednesday, June 3, 2020TEAS EXTENSION RECEIVED
Tuesday, May 26, 2020NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Tuesday, March 31, 2020OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, March 31, 2020PUBLISHED FOR OPPOSITION
Wednesday, March 11, 2020NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Monday, February 24, 2020APPROVED FOR PUB - PRINCIPAL REGISTER
Tuesday, February 18, 2020ASSIGNED TO EXAMINER
Tuesday, November 19, 2019NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Saturday, November 16, 2019NEW APPLICATION ENTERED

Related Keywords

technology angstro disorders system disorder endocrine skeletal musculo musculoskeletal neurological diseases related